title: The influence of ketamine on regional brain glucose use.
abstract: The purpose of this study was to determine the effect of different doses of ketamine on cerebral function at the level of individual brain structures as reflected by glucose use. Rats received either 5 or 30 mg/kg ketamine intravenously as a loading dose, followed by an infusion to maintain a steady-state level of the drug. An additional group received 30 mg/kg as a single injection only, and was studied 20 min later, by which time they were recovering consciousness (withdrawal group). Regional brain energy metabolism was evaluated with [6-14C]glucose and quantitative autoradiography during a 5-min experimental period. A subhypnotic, steady-state dose (5 mg/kg) of ketamine caused a stimulation of glucose use in most brain areas, with an average increase of 20%. At the larger steady-state dose (30 mg/kg, which is sufficient to cause anesthesia), there was no significant effect on most brain regions; some sensory nuclei were depressed (inferior colliculus, -29%; cerebellar dentate nucleus, -18%; vestibular nucleus, -16%), but glucose use in the ventral posterior hippocampus was increased by 33%. In contrast, during withdrawal from a 30-mg/kg bolus, there was a stimulation of glucose use throughout the brain (21-78%), at a time when plasma ketamine levels were similar to the levels in the 5 mg/kg group. At each steady-state dose, as well as during withdrawal, ketamine caused a notable stimulation of glucose use by the hippocampus.
authors.affiliation: Department of Anesthesia, Pennsylvania State University, College of Medicine, Milton S. Hershey Medical Center, Hershey 17033.
authors.forename: D W
authors.initials: DW
authors.lastname: Davis
authors.forename: A M
authors.initials: AM
authors.lastname: Mans
authors.forename: J F
authors.initials: JF
authors.lastname: Biebuyck
authors.forename: R A
authors.initials: RA
authors.lastname: Hawkins
mesh_terms: D000771:Anesthesia, Intravenous; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D002250:Carbon Radioisotopes; D005947:Glucose / Q000378:metabolism*; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D007260:Infusion Pumps; D007649:Ketamine / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D051381:Rats; D013053:Spectrophotometry; D013268:Stimulation, Chemical
chemical_list: D001786:Blood Glucose; D002250:Carbon Radioisotopes; D007649:Ketamine; D005947:Glucose